Conference Call on Daiichi Sankyo's Cancer Enterprise

Thursday, August 31, 2017

Date: August 31st, Thursday 23:00-24:00
Sponsorship: UBS Securities
For institutional investors
Topic: Cancer Enterprise Progress from June 2017, Highlights of DS-8201 Data from ASCO 2017
Speaker: Antoine Yver MD, MSc, EVP, Global Head of Oncology R&D and Chair of Cancer Enterprise

Related Data

In order to view the PDF files, you need to have the latest version of Adobe Reader installed.